Skip to main content

Research

The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

On June 5, Xeris Pharmaceuticals announced that the first patient had been dosed in its phase 2 clinical trial , which is testing “mini-dose” glucagon for the treatment...
Twitter Summary: @DpT1D of the #helmsleytrust talks about need 4 philanthropic support in #T1D in inspiring Wired op-ed David Panzirer , a trustee of the Helmsley...
Debates in type 1 diabetes – what is the future of technology and what is a “cure"? Part three of our interview with David Panzirer and Dana Ball.
On September 24, JAMA published a paper on long-term trends in the number of people with diabetes in the United States from 1980 to 2012. The results showed a leveling-...
Advances for type 2 diabetes at The American Diabetes Association 74th Scientific Sessions
Twitter summary: A new technology from Stanford has potential for easier, more accurate, & cheaper diagnosis for #t1d A team of Stanford University researchers, with...
The T1D Exchange: a bold vision to advance the field of type 1 diabetes – part four of our interview with David Panzirer and Dana Ball.
The hope and hype of curing diabetes with stem cells – our take on the Harvard research and more.
After the rapid-acting inhaled insulin Afrezza launched this February, we have been very eager to learn more about how this new product impacts patients’ day-to-day...
Plus, their report on the greatest challenges and opportunities in the field.
Twitter summary: new @ADA_Journals study reports skyrocketing costs of prediabetes and #diabetes in the US – $322 billion a year! The ADA recently announced results from...
Twitter Summary: Wearing UVA’s DiAs #artificialpancreas in a 3-month study testing overnight and 24-hr closed-loop at home; learnings, surprises, next steps
Insights from the largest ever global study on the pressing mental and emotional needs of people with diabetes: DAWN2.
How this initiative aims to bring actionable recommendations from overwhelming data.
The two trillion dollar problem – a new report provides a groundbreaking look at the worldwide cost of obesity.
Starting in 2012, the American Diabetes Association established the Pathway to Stop Diabetes initiative, a $1.6 million grant (paid over five years) to support the...
What’s next for getting this software to patients?
Kicking off this weekend, what are we most excited about for this year’s ADA?
How these two FDA-submitted drugs could address this major healthcare need.
There was a lot of interest this ADA in the Harvard Stem Cell Institute's diabetes research (not yet in humans), which has previously shown the ability to produce mature...

Pages